HighLife Receives IDE Approval to Initiate US Pivotal Clinical Study for treatment of Mitral Regurgitation
GlobeNewswire
*HighLife Receives IDE Approval to Initiate US Pivotal Clinical Study *
*for treatment of Mitral..
*HighLife Receives IDE Approval to Initiate US Pivotal Clinical Study *
*for treatment of Mitral..
Fleets grapple with regulatory uncertainty and differences across jurisdictions while facing growing pains with new technologies...
NEW YORK, May 12, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm,..